CNTA
Centessa Pharmaceuticals-adr
$6.08
Earnings Summary
Net Profits | $-24.89Mn |
Highlights
Centessa Pharmaceuticals-adr’s net profit jumped 61.51% since last year same period to $-24.89Mn in the Q2 2023. On a quarterly growth basis, Centessa Pharmaceuticals-adr has generated 50.93% jump in its net profits since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Centessa Pharmaceuticals-adr post its latest quarter earnings
EPS Estimate Current Quarter | -0.49 |
EPS Estimate Current Year | -0.49 |
Highlights
Centessa Pharmaceuticals-adr’s earning per share (EPS) estimates for the current quarter stand at -0.49 - a -12.66% fall from last quarter’s estimates.
Centessa Pharmaceuticals-adr’s earning per share (EPS) estimates for the current year stand at -0.49.
Key Ratios
Key ratios of the Centessa Pharmaceuticals-adr post its Q3 2023 earnings
Earning Per Share (EPS) | 0 |
Highlights
Centessa Pharmaceuticals-adr’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2023. This indicates that the Centessa Pharmaceuticals-adr has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-05-12 | -0.47 | 0 | 100% |
2023-11-13 | -0.49 | 0 | 100% |
2023-08-14 | -0.44 | 0 | 100% |
₹0 US Stocks a/c Opening Fee